Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DYRK1A | Q13627 | 1/20 | 0.34 |
| ▸ | MAPK8 | P45983 | 7/20 | 0.33 |
| ▸ | MARK3 | P27448 | 2/20 | 0.32 |
| ▸ | SYK | P43405 | 2/20 | 0.32 |
| ▸ | GSK3B | P49841 | 2/20 | 0.32 |
| ▸ | PLK1 | P53350 | 2/20 | 0.32 |
| ▸ | CAMK2B | Q13554 | 2/20 | 0.32 |
| ▸ | MARK2 | Q7KZI7 | 2/20 | 0.32 |
| ▸ | MINK1 | Q8N4C8 | 2/20 | 0.32 |
| ▸ | SRPK1 | Q96SB4 | 2/20 | 0.32 |
| ▸ | HIPK2 | Q9H2X6 | 2/20 | 0.32 |
| ▸ | PLK3 | Q9H4B4 | 2/20 | 0.32 |
| ▸ | CDC7 | O00311 | 1/20 | 0.32 |
| ▸ | IRAK1 | P51617 | 1/20 | 0.32 |
| ▸ | NEK4 | P51957 | 1/20 | 0.32 |
| ▸ | MAP4K2 | Q12851 | 1/20 | 0.32 |
| ▸ | CDC42BPA | Q5VT25 | 1/20 | 0.32 |
| ▸ | TAOK1 | Q7L7X3 | 1/20 | 0.32 |
| ▸ | HIPK4 | Q8NE63 | 1/20 | 0.32 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25248815 | 0.92 | TP53 (0.35) | DYRK1AMAPK8POLBPTGS2ALDH1A1 | |
| SCHEMBL25249377 | 0.92 | MAPK8 (0.35) | MAPK8MARK3SYKGSK3BPLK1 | |
| SCHEMBL23000228 | 0.86 | MARK3 (0.37) | MAPK8MARK3SYKGSK3BPLK1 | |
| SCHEMBL25786220 | 0.86 | MARK3 (0.37) | DYRK1AMAPK8MARK3SYKGSK3B | |
| SCHEMBL25250674 | 0.85 | SIRT2 (0.35) | MAPK8MARK3SYKGSK3BPLK1 | |
| SCHEMBL25250550 | 0.81 | ALOX5 (0.38) | MARK3SYKGSK3BPLK1CAMK2B | |
| SCHEMBL25246284 | 0.80 | TP53 (0.36) | MAPK8POLBALDH1A1KDM4EMAPT | |
| SCHEMBL25293250 | 0.80 | TP53 (0.35) | POLBALDH1A1KDM4EMAPTNPSR1 | |
| SCHEMBL25292064 | 0.79 | BAD (0.33) | MAPK8 | |
| SCHEMBL25786239 | 0.78 | MAPK8 (0.35) | DYRK1AMAPK8MARK3SYKGSK3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11691989-B2 | Macrocyclic indoles as Mcl-1 inhibitors | ASCENTAGE PHARMA (SUZHOU) CO., LTD. (CN) | 2023-07-04 | — | — | US | disclosed |
| US-20220340595-A1 | MACROCYCLIC INDOLES AS MCL-1 INHIBITORS | ASCENTAGE PHARMA (SUZHOU) CO., LTD. (CN) | 2022-10-27 | — | — | US | disclosed |
| CN-110845520-B | Macrocyclic indoles as MCL-1 inhibitors | 苏州亚盛药业有限公司 | 2021-04-13 | — | — | CN | disclosed |
| EP-3781570-A1 | MACROCYCLIC INDOLES AS MCL-1 INHIBITORS | Ascentage Pharma (Suzhou) Co., Ltd. (CN) | 2021-02-24 | — | — | EP | disclosed |
| CN-110845520-A | Macrocyclic indoles as MCL-1 inhibitors | 苏州亚盛药业有限公司 | 2020-02-28 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220340595-A1 | MACROCYCLIC INDOLES AS MCL-1 INHIBITORS | MCL1, BCL2A1, BCL2L1 | DYRK1A 1043/4885MAPK8 3126/4885MARK3 1429/4885 |
| US-11691989-B2 | Macrocyclic indoles as Mcl-1 inhibitors | MCL1, BCL2A1, BCL2L1 | DYRK1A 1043/4885MAPK8 3126/4885MARK3 1429/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.